Guardant Health
GH
#3260
Rank
โ‚น303.57 B
Marketcap
โ‚น2,457
Share price
-3.64%
Change (1 day)
32.20%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Revenue for Guardant Health (GH)

Revenue in 2024 (TTM): โ‚น53.62 Billion

According to Guardant Health 's latest financial reports the company's current revenue (TTM ) is โ‚น54.34 Billion. In 2023 the company made a revenue of โ‚น46.94 Billion an increase over the revenue in the year 2022 that were of โ‚น37.19 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Guardant Health from 2018 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น53.62 B14.23%
2023 โ‚น46.94 B26.21%
2022 โ‚น37.19 B33.76%
2021 โ‚น27.81 B32.63%
2020 โ‚น20.96 B37.17%
2019 โ‚น15.28 B141.21%
2018 โ‚น6.33 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น114.83 B 111.32%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น76.99 B 41.69%๐Ÿ‡บ๐Ÿ‡ธ USA